Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2003
07/10/2003WO2003002749A3 Methods for the simultaneous detection of hcv antigens and hcv antibodies
07/10/2003WO2002092625A3 Moraxella(branhamella) catarrhalis antigens
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002088306A3 Humanized antibodies
07/10/2003WO2002072788A3 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses
07/10/2003WO2002063008A3 Intracellular signaling molecules
07/10/2003WO2002061435A3 Subunit vaccines with a2 supermotifs
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002040541A3 Transporters and ion channels
07/10/2003WO2002018581A3 G-protein coupled receptors
07/10/2003WO2002000730A9 Pd-l2 molecules: novel pd-1 ligands and uses therefor
07/10/2003US20030131383 Peptides with enhanced stability to protease degradation
07/10/2003US20030131381 Novel ecdysone receptors and methods for their use
07/10/2003US20030130496 Immunoglobulins; cloning, amplifying and encoding by DNA sequences, polymerase chain reaction
07/10/2003US20030130494 Mammalian chemokine reagents
07/10/2003US20030130491 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130490 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins; extracellular
07/10/2003US20030130489 Genetic engineered protein drugs, such as thrombolytic agents, interferons, interleukins, erythropoietins
07/10/2003US20030130486 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects
07/10/2003US20030130483 Amino acid sequences free of signal peptide, encoded by cDNA; fusion proteins
07/10/2003US20030130218 Methods of stimulating phagocytosis
07/10/2003US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130181 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129746 Monoclonal antibodies for Hepatitis C virus (HCV) infection
07/10/2003US20030129726 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
07/10/2003US20030129720 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
07/10/2003US20030129707 Producing a crystalline and/or amorphous metabolite suspension by treating the broth with a coagulant and/or a flocculant; and separating the biomass from the broth
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129702 DNA encoding galanin GALR2 receptors and uses thereof
07/10/2003US20030129701 Detecting a mutation in the RAR epsilon receptor nucleic acid sequences and detecting a level of the soluble form of the receptors
07/10/2003US20030129698 Involved in homo and heterotrimerization or oligomerization
07/10/2003US20030129697 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis
07/10/2003US20030129695 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129694 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129693 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129692 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129690 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule
07/10/2003US20030129689 Nucleotide sequence that encodes a PRO polypeptide.
07/10/2003US20030129688 Heregulin variants
07/10/2003US20030129658 Novel protease
07/10/2003US20030129655 Nucleic acids encoding GTPase activating proteins
07/10/2003US20030129650 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030129644 Used in gene therapy
07/10/2003US20030129628 Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease
07/10/2003US20030129592 Identification and characterization of extracellular polypeptides having homology to EGF
07/10/2003US20030129582 Method for determining early HCV seroconversion
07/10/2003US20030129207 Obtaining a biological sample from the patient, contacting the sample with a binding agent that binds to a polypeptide, detecting amount of bounded polypeptide, comparing it to a predetermined cut-off value to determine presence of cancer
07/10/2003US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
07/10/2003US20030129196 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
07/10/2003US20030129187 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
07/10/2003US20030129185 Chimeric antibodies; lymphocytes; genetic engineering; for treatment of myeloma
07/10/2003US20030129184 Monoclonal antibody specific to polypeptide which induces interferon-gamma production
07/10/2003US20030129176 Atherosclerosis-associated genes
07/10/2003US20030129174 Antihemophilic factor; insertion of culture product into blood; polypeptide
07/10/2003CA2471667A1 Nucleotide sequences having activity of controlling translation efficiency and utilization thereof
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2471206A1 Individualized anti-cancer antibodies
07/10/2003CA2471130A1 Il-17 like molecules and uses thereof
07/10/2003CA2471042A1 Expression vectors and promoters for heterologous gene expression
07/10/2003CA2470781A1 Cystine-knot fold protein
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2469690A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003CA2468619A1 Adiponectin fragments and conjugates
07/10/2003CA2468081A1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
07/10/2003CA2458751A1 Compositions and methods for the treatement of immune related diseases
07/09/2003EP1325960A2 Negative strand RNA virus vector having autonomously replicating activity
07/09/2003EP1325957A2 Recombinant papilloma virus L1
07/09/2003EP1325956A1 Plant lesion formation suppressing gene, sp17 and use theriof
07/09/2003EP1325932A2 Anti-vegf antibodies
07/09/2003EP1325929A2 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants
07/09/2003EP1325338A2 Diagnosis and treatment of alzheimer's disease
07/09/2003EP1325147A2 Industrial-scale serum-free production of recombinant factor vii in mammalian cells
07/09/2003EP1325133A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus
07/09/2003EP1325130A2 Nogo receptor homologs
07/09/2003EP1325128A2 Lipocalins
07/09/2003EP1325127A2 Method for the production of vitamin k-dependent proteins
07/09/2003EP1325117A2 Lipid metabolism enzymes
07/09/2003EP1325115A2 Cytokine receptor zcytor17
07/09/2003EP1325113A2 Factor vii glycoforms
07/09/2003EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof
07/09/2003EP1325028A2 New inhibitors of iapp fibril formation and uses thereof
07/09/2003EP1325027A2 Casein peptide fragments with growth-influencing activity on cell cultures
07/09/2003EP1324768A2 Vaccines for proliferative ileitis
07/09/2003EP1071752B1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
07/09/2003EP0988316A4 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
07/09/2003EP0741787B1 Mammalian expression systems for hepatitis c virus envelope genes
07/09/2003EP0686260B1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
07/09/2003EP0686194B1 Harp family growth factors, preparation methods therefor and uses thereof
07/09/2003EP0668924B1 HUMANIZED ANTIBODIES TO Fc RECEPTORS FOR IMMUNOGLOBULIN G ON HUMAN MONONUCLEAR PHAGOCYTES
07/09/2003EP0619738B1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor
07/09/2003EP0511308B2 Chimeric immunoglobulin for cd4 receptors
07/09/2003CN1429275A Matrix reactor and method for producing products in said reactor
07/09/2003CN1429273A Protection against environmental toxicity through manipulation of processing of messenger RNA precursors
07/09/2003CN1428431A Method for preparing soybean polypeptide by utilizing ereyme method
07/09/2003CN1428426A Programmed cell death induction molecule II
07/09/2003CN1428425A Contruction and purification process of recombinant human soluble necrohormone 2 ligand
07/09/2003CN1428354A Wheat high-molecular-weight glutelin subunit monoclonal antibody and its hybrid tumor cell line
07/09/2003CN1428353A Antihuman hemoglobin monoclonal antibody
07/09/2003CN1428352A Reformed monoclonal antibody for resisting immunoglobulin homoeotype
1 ... 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 ... 1125